Clinical Trial

CYP1A2 and ADORA2A Genotypes and Endurance Performance.

Name: CYP1A2 and ADORA2A Genotypes and Endurance Performance. — clinical trial record (NCT06547307)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated August 9, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.

Summary

The aim of this randomized, double-blind, placebo-controlled experiment will be to assess the potential effect of the selected gene polymorphism (CYP1A2, ADORA2A) on performance after caffeine ingestion.

Trial Details

NCT Number	NCT06547307
Lead Sponsor	Masaryk University
Conditions	Healthy
Enrollment	60 participants
Start Date	2024-08
Primary Completion	2025-01 (estimated)
Study Completion	2025-03 (estimated)
Updated on ClinicalTrials.gov	2024-08-09